FREE WEBINAR
Rapid AST: It's About Time
… to improve patient care, limit antibiotic exposure, save money - and save lives
Airing On February 6, 2025
60-Minute Webinar Sponsored By
Join our webinar to discover innovative Rapid Antimicrobial Susceptibility Testing (AST) that can improve patient care and antibiotic stewardship!
Antimicrobial susceptibility testing (AST) is a bedrock diagnostic in the clinical microbiology laboratory. Faster AST results can, in principle, improve treatment of acute infections and assist in antimicrobial stewardship. This webinar will introduce rapid AST principles of operation, present an evaluation of rapid AST performance in a leading diagnostic lab, and discuss how it can improve patient care and support antibiotic stewardship.
Join us for a deep dive into Dr. James Snyder's clinical evaluation of the LifeScale AST system at the University of Louisville Hospital. This study rigorously compared rapid AST speed and accuracy with those of conventional ASTs that serve as the current standard of care. Dr. Snyder will also describe the practicalities of integrating rapid AST into the lab workflow, how same-shift results can speed escalation and de-escalation and reduce exposure to broad spectrum antibiotics, and even save hospitals money.
This free 60-minute webinar, sponsored by Affinity Biosensors and hosted by Dark Daily, is your chance to learn about Rapid Antimicrobial Susceptibility Testing and determine if it can help your lab and your patients.
Please join us on Thursday, February 6, 2025, at 1:00 pm ET.
Key Learnings:
During this webinar, you will:
- Identify the principles of rapid AST operation and discuss how to assess its capabilities and limitations
- Discuss how rapid AST can improve patient care and antibiotic stewardship, facilitate escalation and de-escalation of treatment, limit exposure to broad-spectrum antibiotics – and save money
- Evaluate rapid AST accuracy, ease of use, and cost- effectiveness – and whether it is right for your lab
- Review rapid AST capabilities which are available now, and will be available in the future for emerging challenges such as C. auris
Expert Speakers
Dr. James Snyder PhD, D(ABMM), F(AAM)
Prof., Dept. of Pathology and Laboratory Medicine and Chief of Microbiology
University of Louisville Hospital
Dr. Snyder is currently the Director of Microbiology and Infectious Disease Molecular Diagnostics at the University of Louisville Hospital, Louisville, KY. He holds the academic rank of Professor of Pathology and Laboratory Medicine in the Department of Pathology and Laboratory Medicine, University of Louisville School of Medicine. He is board certified in Medical Microbiology and Public Health by the American Academy of Microbiology (AAM) and a Fellow in the AAM. Dr. Snyder holds professional memberships in the American Society for Microbiology (ASM), South Central Association for Clinical Microbiology (SCACM), the Infectious Disease Society of America (IDSA), and the Pan American Society for Clinical Virology (PASCV).
Dr. Ken Babcock, PhD
CEO
Affinity Biosensors
Ken is the CEO of Affinity Biosensors and has led the development of the LifeScale rapid AST platform since 2014. Ken’s background in science and technology includes research in physics and commercial analytical instrumentation before cofounding Affinity Biosensors. He has held key leadership and R&D roles in atomic force microscopy, nanoscale metrology, and biosensor development and has led teams to win multiple industry honors, secured patents in advanced diagnostics, and established collaborative partnerships with top research institutions.
Who should attend?
- Clinical and Research Laboratory Directors
- Infectious Diseases Physicians
- Hospital and Laboratory Diagnostics Providers
- Pharmacy Doctors
- Medical Directors and Executives
Hosted By
